(Q43024151)

12 November 2017

title

Transcriptional changes associated with recovery from heart failure in the SHR. (English)

1 reference

12 November 2017

Wesley W Brooks

1

1 reference

12 November 2017

Steven Shen

2

1 reference

12 November 2017

Chester H Conrad

3

1 reference

12 November 2017

Ronald H Goldstein

4

1 reference

12 November 2017

Lingyi Lynn Deng

5

1 reference

12 November 2017

Oscar H L Bing

6

1 reference

12 November 2017

language of work or name

1 reference

12 June 2010

1 reference

Journal of Molecular and Cellular Cardiology

12 November 2017

published in

1 reference

12 November 2017

volume

49

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

390-401

1 reference

Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Captopril modifies gene expression in hypertrophied and failing hearts of aged spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Transcriptomal analysis of failing and nonfailing human hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Cardiac gene expression profile in rats with terminal heart failure and cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

DNA microarray analysis of in vivo progression mechanism of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Transcriptomic profiling of the canine tachycardia-induced heart failure model: global comparison to human and murine heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

A systematic review of large scale and heterogeneous gene array data in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Myocardial substrate metabolism in the normal and failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Energy metabolism in heart failure and remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Cardiac metabolism as a target for the treatment of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Mitochondrial preference for short chain fatty acid oxidation during coronary artery constriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Mitochondrial energy metabolism in heart failure: a question of balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Adaptation and maladaptation of the heart in diabetes: Part II: potential mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

New secondary metabolites of phenylbutyrate in humans and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Hypertrophic stimuli induce transforming growth factor-beta 1 expression in rat ventricular myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Mitochondrial centrality in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Metabolic energetics and genetics in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Plasma cytokine parameters and mortality in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Alterations of gene expression in failing myocardium following left ventricular assist device support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Inhibition of PPAR-α activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-β/Smad3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Phenylbutyrate decreases type I collagen production in human lung fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Life extension in Drosophila by feeding a drug.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis bronchial epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

The effect of lathyrogen beta-amino proprionitrile (BAPN) on the mechanical properties of experimentally hypertrophied rat cardiac muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2010.06.002

10.1016/J.YJMCC.2010.06.002

7 January 2021

Identifiers

DOI

1 reference

release_6fhzu73aufb63drcai4dy6wshi

12 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6fhzu73aufb63drcai4dy6wshi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference